EMPLOYMENT AGREEMENTEmployment Agreement • November 15th, 2023 • Mural Oncology PLC • Pharmaceutical preparations • Massachusetts
This Employment Agreement (“Agreement”) is between Mural Oncology, Inc., a Delaware Corporation, (“Mural”), and Adam Cutler (the “Executive”), and is effective as of November 15, 2023 (the “Effective Date”).
TRANSITION SERVICES AGREEMENT by and between ALKERMES, INC. and MURAL ONCOLOGY, INC. Dated as of November 13, 2023Transition Services Agreement • November 15th, 2023 • Mural Oncology PLC • Pharmaceutical preparations • Delaware
This TRANSITION SERVICES AGREEMENT (this “Agreement”), dated as of November 13, 2023 (the “Effective Date”), is entered into by and between Alkermes, Inc., a Pennsylvania corporation and wholly owned indirect subsidiary of Alkermes plc (“Alkermes US”), and Mural Oncology, Inc., a Delaware corporation and, following the Separation, a wholly owned direct subsidiary of Mural Oncology plc (“Mural US”). “Party” or “Parties” means Alkermes US or Mural US, individually or collectively, as the case may be.
SEPARATION AGREEMENT by and between ALKERMES PLC and MURAL ONCOLOGY PLC Dated as of November 13, 2023Separation Agreement • November 15th, 2023 • Mural Oncology PLC • Pharmaceutical preparations • Delaware
This SEPARATION AGREEMENT (this “Agreement”), dated as of November 13, 2023, is entered into by and between Alkermes plc, an Irish public limited company (“Alkermes”), Mural Oncology plc, an Irish public limited company (“Mural”), and, solely with respect to Article II, Section 4.5 and Section 7.12, Mural Oncology, Inc., a Delaware corporation (“Mural US”). “Party” or “Parties” means Alkermes, Mural or Mural US, individually or collectively, as the case may be. Each capitalized term used and not elsewhere defined herein has the meaning set forth in Section 1.1.
AMENDMENT TO EMPLOYEE MATTERS AGREEMENTEmployee Matters Agreement • March 26th, 2024 • Mural Oncology PLC • Pharmaceutical preparations
This amendment (the “Amendment”) to that certain Employee Matters Agreement, dated November 13, 2023 (the “Employee Matters Agreement”), between Alkermes plc (“Alkermes”), an Irish public limited company, and Mural Oncology plc (“Mural”), an Irish public limited company, is entered into as of December 14, 2023 by and among Alkermes and Mural. Any term used in this Amendment without definition has the meaning set forth for such term in the Employee Matters Agreement.
TAX MATTERS AGREEMENT by and between ALKERMES PLC and MURAL ONCOLOGY PLC Dated as of November 13, 2023Tax Matters Agreement • November 15th, 2023 • Mural Oncology PLC • Pharmaceutical preparations • Delaware
This TAX MATTERS AGREEMENT (this “Agreement”) is entered into as of November 13, 2023, by and between Alkermes plc, an Irish public limited company (“Alkermes”), and Mural Oncology plc, an Irish public limited company (“Mural”). (Alkermes and Mural are sometimes collectively referred to herein as the “Parties” and, as the context requires, individually referred to herein as a “Party”).
MURAL ONCOLOGY, INC. FORM OF INDEMNIFICATION AGREEMENTForm of Indemnification Agreement • August 24th, 2023 • Mural Oncology LTD • Pharmaceutical preparations • Delaware
This Indemnification Agreement (“Agreement”) is made as of ________, 20 ___ by and between Mural Oncology, Inc., a Delaware corporation (the “Company”), and [________] (“Indemnitee”).
EMPLOYEE MATTERS AGREEMENT by and between ALKERMES PLC and MURAL ONCOLOGY PLC Dated as of November 13, 2023Employee Matters Agreement • November 15th, 2023 • Mural Oncology PLC • Pharmaceutical preparations • Delaware
This EMPLOYEE MATTERS AGREEMENT (this “Agreement”), dated as of November 13, 2023, is entered into by and between Alkermes plc (“Alkermes”), an Irish public limited company, and Mural Oncology plc (“Mural”), an Irish public limited company. “Party” or “Parties” means Alkermes or Mural, individually or collectively, as the case may be.
EMPLOYMENT AGREEMENTEmployment Agreement • August 24th, 2023 • Mural Oncology LTD • Pharmaceutical preparations • Massachusetts
This Employment Agreement (“Agreement”) is among Alkermes, Inc., a Pennsylvania corporation (including its parent, subsidiaries and other affiliates and its and their successors and assigns, “Alkermes”), Caroline Loew (the “Executive”), and, effective as of the Mural Effective Date (as defined below), Mural Oncology, Inc., a Delaware corporation (including its parent, subsidiaries and other affiliates and its and their successors and assigns, “Mural”).
TRANSITION SERVICES AGREEMENT by and between MURAL ONCOLOGY, INC. and ALKERMES, INC. Dated as of November 13, 2023Transition Services Agreement • November 15th, 2023 • Mural Oncology PLC • Pharmaceutical preparations • Delaware
This TRANSITION SERVICES AGREEMENT (this “Agreement”), dated as of November 13, 2023 (the “Effective Date”), is entered into by and between Mural Oncology, Inc., a Delaware corporation and, following the Separation, a wholly owned direct subsidiary of Mural Oncology plc (“Mural US”), and Alkermes, Inc., a Pennsylvania corporation and wholly owned direct subsidiary of Alkermes plc (“Alkermes US”). “Party” or “Parties” means Mural US or Alkermes US, individually or collectively, as the case may be.
ASSIGNMENT AND ASSUMPTION OF LEASEAssignment and Assumption of Lease • November 15th, 2023 • Mural Oncology PLC • Pharmaceutical preparations
This ASSIGNMENT AND ASSUMPTION OF LEASE (this “Assignment”) is made and entered into as of the 13th day of November, 2023, by and between ALKERMES, INC., a Pennsylvania corporation (“Assignor”) and MURAL ONCOLOGY, INC., a Delaware Corporation (“Assignee”).
MURAL ONCOLOGY PLC FORM OF DEED OF INDEMNIFICATIONMural Oncology LTD • August 24th, 2023 • Pharmaceutical preparations
This Deed of Indemnification (“Deed”) is made as of , 20 by and between Mural Oncology plc, a public limited company incorporated in Ireland (registered number [●]) having its registered office at [●] (the “Company”) and [ ] ( “Indemnitee”).
LEASE BETWEEN PDM UNIT 850, LLC AND ALKERMES, INC. FOR PREMISES LOCATED AT 850 AND 852 WINTER STREET RESERVOIR WOODS, WALTHAM, MASSACHUSETTSLease • November 15th, 2023 • Mural Oncology PLC • Pharmaceutical preparations
LEASE dated as of April 22, 2009, by and between PDM 850 Unit, LLC, a Delaware limited liability company (hereinafter called “Landlord”), and Alkermes, Inc., a Pennsylvania corporation (hereinafter called “Tenant”).
FORM OF EMPLOYMENT AGREEMENTForm of Employment Agreement • October 10th, 2023 • Mural Oncology PLC • Pharmaceutical preparations • Massachusetts
This Employment Agreement (“Agreement”) is between Mural Oncology, Inc., a Delaware Corporation, (“Mural”), and [ ] (the “Executive”), and is effective as of [ ](the “Effective Date”).
